|
|
 |
|
Viewing report
|
|
|
|
The World Generic Market Report 2011
Espicom Business Intelligence Ltd, Feb 2011, Pages: 648
A complete global analysis of the prospects for markets and companies in this dynamic industry sector
Features and benefits of this thoroughly-researched and highly-regarded management report:
- High quality: Original research, novel 5-year market forecasts and informed commentary from our experienced editors are allied with unrivalled primary source data
- Global coverage: Covers leading economies as well as key emerging markets such as China, Russia and Brazil
- Issue driven: Understand the latest company, product, and regulatory developments
- Company Focus: Who’s working with whom? Who’s suing whom? Who’s up, who’s down? Detailed and frank appraisals of 28 leading companies in the field
- Flexible formats: Available in pdf or print with web access included in the price. Cost-effective distribution licences can ensure you get the best from your investment
Easily understand the threats and opportunities that are shaping this rapidly evolving sector!
Industry consolidation, new market opportunities, the latest on biosimilars plus much, much more!
This leading report, now in its 9th year of publication, draws on primary research with companies, statistics offices, health ministries and trade associations worldwide and provides standard, comparative data and discussion on key issues. This extensive data set is interpreted and evaluated by the editors to provide a complete and compelling review of the whole sector.
Key facts, issues and questions:
- Industry collaboration - more and more branded companies are taking an interest in generics - we identify and assess the companies involved
- US biosimilar regulatory progress - on the statute book but a long way from the market
- Unblocking the US ANDA approval delays - action by the FDA and what it will mean
- The EU’s anti-competitive investigation: more of the same - what are the issues?
- The political, regulatory and funding background in key markets
- What pricing and production issue must generic companies overcome in Brazil?
- Low market penetration of generics makes Italy an attractive proposition for generic manufacturers but what are the challenges?
- How generic companies are faring in the recession
- Who is involved in the latest legal challenges and litigation?
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
